Gastric Gastrointestinal Stromal Tumor with Repeated Recurrence at the Anastomosis Site in a Very Elderly Patient

Korean J Gastroenterol. 2020 Oct 25;76(4):206-210. doi: 10.4166/kjg.2020.76.4.206.

Abstract

Although high-risk gastrointestinal stromal tumors (GISTs) frequently recur, even after a complete resection and imatinib therapy, local recurrence at the suture line after complete resection is rare. The present case was an 88-year-old woman who was initially diagnosed with high-risk GIST without a distant metastasis. She underwent a complete surgical resection of the lesion and received adjuvant imatinib therapy for 18 months, which was discontinued due to severe drug-induced anemia. During the follow- up, an endoscopic examination performed 40 months after the initial surgery revealed local recurrence at the anastomosis site. Although a complete surgical resection was performed, repeated local recurrence was detected 18 months later, which progressed rapidly to metastatic disease. This paper reports a case of a completely resected gastric GIST with repeated local recurrence, despite the complete surgical resections and adjuvant imatinib therapy.

Keywords: Gastrointestinal stromal tumors; Imatinib mesylate; Recurrence; Surgery.

Publication types

  • Case Reports

MeSH terms

  • Abdomen / diagnostic imaging
  • Aged, 80 and over
  • Endoscopy, Gastrointestinal
  • Female
  • Gastrointestinal Neoplasms / diagnosis*
  • Gastrointestinal Neoplasms / drug therapy
  • Gastrointestinal Neoplasms / pathology
  • Gastrointestinal Neoplasms / surgery
  • Gastrointestinal Stromal Tumors / diagnosis*
  • Gastrointestinal Stromal Tumors / drug therapy
  • Gastrointestinal Stromal Tumors / pathology
  • Gastrointestinal Stromal Tumors / surgery
  • Humans
  • Imatinib Mesylate / therapeutic use
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local
  • Protein Kinase Inhibitors / therapeutic use
  • Tomography, X-Ray Computed

Substances

  • Protein Kinase Inhibitors
  • Imatinib Mesylate